The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas.
 
Thierry Conroy
No Relationships to Disclose
 
Pascal Hammel
No Relationships to Disclose
 
Mohamed Hebbar
No Relationships to Disclose
 
Meher Ben Abdelghani
No Relationships to Disclose
 
Alice Chia-chi Wei
No Relationships to Disclose
 
Jean-Luc Raoul
No Relationships to Disclose
 
Laurence Chone
No Relationships to Disclose
 
Eric Francois
No Relationships to Disclose
 
Pascal Artru
No Relationships to Disclose
 
James Joseph Biagi
No Relationships to Disclose
 
Thierry Lecomte
No Relationships to Disclose
 
Eric Assenat
No Relationships to Disclose
 
Roger Faroux
No Relationships to Disclose
 
Marc Ychou
No Relationships to Disclose
 
Julien Volet
No Relationships to Disclose
 
Alain Sauvanet
No Relationships to Disclose
 
Claire Jouffroy-Zeller
No Relationships to Disclose
 
Patrick RAT
No Relationships to Disclose
 
Florence Castan
No Relationships to Disclose
 
Jean-Baptiste Bachet
No Relationships to Disclose